Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Validate, Develop and Implement The Scope of Medical Care for Metastatic, Persistent and Recurrent Cervical Cancer Using The Method of Chemoimmunotargeted Therapy

NCT07472153 is registered in ClinicalTrials.gov with N.N. Alexandrov National Cancer Centre as lead sponsor.

NCT NCT07472153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07472153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Validate, Develop and Implement The Scope of Medical Care for Metastatic, Persistent and Recurrent Cervical Cancer Using The Method of Chemoimmunotargeted Therapy
Lead sponsor
N.N. Alexandrov National Cancer Centre
Phase
Phase 2/3
Overall status
Recruiting
Start date
July 1, 2025
Completion date
June 30, 2033
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cervical cancer, persistent cervical cancer, recurrent cervical cancer